The Fetomaternal Outcome of Pregnancy in Women with Thyroid Disease

Authors

  • Faryal Khan DHQ Dir
  • Naina Khan Khyber Teaching Hospital, Peshawar
  • Zubaida Akhtar Khyber Teaching Hospital, Peshawar

Keywords:

Pregnancy, Thyroid Disease, Postpartum Haemorrhage

Abstract

OBJECTIVES

To determine the frequency of fetomaternal outcomes in women with pregnancy with thyroid disease presented to Khyber Teaching Hospital Peshawar. 

METHODOLOGY

A descriptive observational study was conducted in Khyber’s Obstetrics and Gynecology Department Teaching Hospital Peshawar from February to July 2022. A total of 160 pregnant patients with thyroid disease were included in the study. All patients were followed till delivery, and fetomaternal outcomes (gestational hypertension, pre-eclampsia, postpartum hemorrhage, mode of delivery, Oligohydramnios, birth weight, neonatal hyperbilirubinemia) were noted.

RESULTS
The age range in this study was from 18 to 40 years with a mean age of 29.787 +2.23 years, mean gestational age of 25.331+4.14 weeks, mean parity of 1.818+1.23 and mean weight of 68.462+3.30 kg. Hypothyroidism was seen in 76.9% of patients, and hyperthyroidism was seen in 23.1%. Gestational hypertension was observed in 11.9%, pre-eclampsia in 5%, postpartum haemorrhage in 47.5%, the cesarean section in 27.5%, Oligohydramnios in 11.3%, low birth weight in 21.3% and neonatal hyperbilirubinemia in 10.6%.

CONCLUSION

The most frequent complication observed in pregnancy with thyroid disease was postpartum haemorrhage, followed by cesarean section and low birth weight.

Downloads

Download data is not yet available.

Metrics

Metrics Loading ...

Author Biographies

Faryal Khan, DHQ Dir

Woman Medical Officer,
DHQ Dir

Naina Khan, Khyber Teaching Hospital, Peshawar

Trainee Medical Officer,
Department of Paediatric A Unit,
Khyber Teaching Hospital, Peshawar

Zubaida Akhtar, Khyber Teaching Hospital, Peshawar

Associate Professor,
Department of Gynae C Unit,
Khyber Teaching Hospital, Peshawar

References

Khan I, Okosieme OE, Lazarus JH. Current challenges in the pharmacological management of thyroid dysfunction in pregnancy. Expert Rev Clin Pharmacol. 2017;10:97–109

Rotondi M, Chiovato L, Pacini F, Bartalena L, Vitti P. Management of subclinical hypothyroidism in pregnancy: a comment from the Italian society of endocrinology (SIE) and the Italian thyroid association (AIT) to the 2017 ATA guidelines. Thyroid. 2018;28:551–5

Delitala AP, Capobianco G, Cherchi PL, Dessole S, Delitala G. Thyroid function and thyroid disorders during pregnancy: a review and care pathway. Arch Gynecol Obstet. 2019;299:327–38

Zhou M, Wang M, Li J, Luo X, Lei M. Effects of thyroid diseases on pregnancy outcomes. Exp Ther Med. 2019;18(3):1807-15

Medenica S, Nedeljkovic O, Radojevic N, Stojkovic M, Trbojevic B, Pajovic B. Thyroid dysfunction and thyroid autoimmunity in euthyroid women in achieving fertility. Eur Rev Med Pharmacol Sci. 2015;19:977–87

Noten AM, Loomans EM, Vrijkotte TG, van de Ven PM, van Trotsenburg AS, Rotteveel J, et al. Maternal hypothyroxinaemia in early pregnancy and school performance in 5-year-old offspring. Eur J Endocrinol. 2015;173:563–71

Gilbert EW, Tay CT, Hiam DS, Teede HJ, Moran LJ. Comorbidities and complications of polycystic ovary syndrome: an overview of systematic reviews. Clin Endocrinol. 2018;89:683–99

Kiran Z, Sheikh A, Malik S, Meraj A, Masood M, Ismail S, et al. Maternal characteristics and outcomes affected by hypothyroidism during pregnancy (maternal hypothyroidism on pregnancy outcomes, MHPO-1). BMC Pregnancy Childbirth. 2019;19(1):476

Sreelatha S, Nadagoudar S, Devi AL. The study of maternal and fetal outcome in pregnant women with thyroid disorders. Int J Reprod Contracept Obstet Gynecol. 2017;6:3507-13

Pongponich S, Ghaffar A, Gilani SA. Determinants of giving birth in a health facility; analysis of three Pakistan demographic health surveys. JPMA J Pak Med Assoc. 2019;69(5):615–20

Yousafzai AK, Rasheed MA, Rizvi A, Armstrong R, Bhutta ZA. Effect of integrated responsive stimulation and nutrition interventions in the lady health worker programme in Pakistan on child development, growth, and health outcomes: a cluster-randomised factorial effectiveness trial. Lancet. 2014;384(9950):1282–93

Klein R, Haddow J, Falx J, Brown R, Hermos R, Pulkkinen A, et al. Prevalence of thyroid deficiency in pregnant women. Clin Endocrinol.1991;35(1):41–6

Dhanwal DK, Bajaj S, Rajput R, Subramaniam K, Chowdhury S, Bhandari R, et al. Prevalence of hypothyroidism in pregnancy: an epidemiological study from 11 cities in 9 states of India. Indian J Endocrinol Metab. 2016;20(3):387

Reh A, Grifo J, Danoff A. What is a normal thyroid-stimulating hormone (TSH) level? Effects of stricter TSH thresholds on pregnancy outcomes after in vitro fertilization. Fertil Steril. 2010;94(7):2920–2

Mannisto T, Vaarasmaki M, Pouta A, Hartikainen A-L, Ruokonen A, Surcel HM, et al. Thyroid dysfunction and autoantibodies during pregnancy as predictive factors of pregnancy complications and maternal morbidity in later life. J Clin Endocrinol Metab. 2010;95(3):1084–94

Saki F, Dabbaghmanesh MH, Ghaemi SZ, Forouhari S, Omrani GR, Bakhshayeshkaram M. Thyroid function in pregnancy and its influences on maternal and fetal outcomes. Int J Endocrinol Metab. 2014;12(4)

Taylor PN, Minassian C, Rehman A, Iqbal A, Draman MS, Hamilton W, et al. TSH levels and risk of miscarriage in women on long-term levothyroxine: a community-based study. J Clin Endocrinol Metab. 2014;99(10):3895–902

Wilson KL, Casey BM, McIntire DD, Halvorson LM, Cunningham FG. Subclinical Thyroid Disease and the Incidence of Hypertension in Pregnancy. Obstet Gynecol. 2012;119(2, Part 1):315–20

Plowden TC, Schisterman EF, Sjaarda LA, Zarek SM, Perkins NJ, Silver R, et al. Subclinical hypothyroidism and thyroid autoimmunity are not associated with fecundity, pregnancy loss, or live birth. J Clin Endocrinol Metab. 2016; 101(6):2358–65

Khan I, Witczak JK, Hadjieconomou S, Okosieme OE. Preconception thyroidstimulating hormone and pregnancy outcomes in women with hypothyroidism. Endocr Pract. 2013;19(4):656–62

Idris I, Srinivasan R, Simm A, Page RC. Maternal hypothyroidism in early and late gestation: effects on neonatal and obstetric outcome. Clin Endocrinol. 2005;63(5):560–5

Chen S, Zhou X, Zhu H, Yang H, Gong F, Wang L, et al. Preconception TSH and pregnancy outcomes: a population-based cohort study in 184 611 women. Clin Endocrinol. 2017;86(6):816–24

Joshi D, Dewan R, Bharti R, Thariani K, Sablok A, Sharma M, et al. Fetomaternal outcome using new screening criteria of serum TSH for diagnosing hypothyroidism in pregnancy. J Clin Diagn Res. 2015;9(4):QC01

Wang S, Teng WP, Li JX, Wang WW, Shan ZY. Effects of maternal subclinical hypothyroidism on obstetrical outcomes during early pregnancy. J Endocrinol Investig. 2012;35(3):322–5

Nazarpour S, Ramezani Tehrani F, Simbar M, Azizi F. Thyroid dysfunction and pregnancy outcomes. Iran J Reprod Med. 2015;13(7):387–96

Gur EB, Karadeniz M, Inceefe H, Tatar S, Turan G, Genc M, et al. Thyroid antibodies in euthyroid and subclinical hypothyroidic pregnant women with autoimmune hypothyroidism: effects on hematological parameters and postpartum hemorrhage. Ginekol Pol. 2015;86(9):666–71

Downloads

Published

2024-09-30

How to Cite

Faryal Khan, Naina Khan, & Akhtar, Z. (2024). The Fetomaternal Outcome of Pregnancy in Women with Thyroid Disease. Journal of Gandhara Medical and Dental Science, 11(4), 31–37. Retrieved from http://jgmds.org.pk/index.php/JGMDS/article/view/607